___

• KAYNAKLAR Referans 1. Bulletins--Gynecology ACoP. ACOG practice bulletin No. 85: pelvic organ prolapse. Obstet Gynecol. 2007;110(3):717-29. Referans 2. Hagen S, Thakar R. Conservative management of pelvic organ prolapse. Obstetrics, Gynaecology & Reproductive Medicine. 2015;25(4):91-5. Referans 3. Panman C, Wiegersma M, Kollen B, Berger M, Leeuwen LV, Vermeulen K, et al. Two‐year effects and cost‐effectiveness of pelvic floor muscle training in mild pelvic organ prolapse: a randomised controlled trial in primary care. BJOG. 2016. Referans 4. Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database Syst Rev. 2011(12):CD003882. Referans 5. Hagen S, Stark D, Maher C, Adams E. Conservative management of pelvic organ prolapse in women. The Cochrane database of systematic reviews. 2006(4):CD003882. Referans 6. Digesu GA, Chaliha C, Salvatore S, Hutchings A, Khullar V. The relationship of vaginal prolapse severity tosymptoms and quality of life. BJOG. 2005;112(7):971-6. Referans 7. Chow D, Rodríguez LV. Epidemiology and prevalence of pelvic organ prolapse. Curr opin urol 2013;23(4):293-8. Referans 8. Durnea C, Khashan A, Kenny L, Durnea U, Smyth M, O’Reilly B. Prevalence, etiology and risk factors of pelvic organ prolapse in premenopausal primiparous women. Int Urogynecol J. 2014;25(11):1463-70. Referans 9. Mothes A, Radosa M, Altendorf-Hofmann A, Runnebaum I. Risk index for pelvic organ prolapse based on established individual risk factors. Arch Gynecol Obstet. 2015:1-8. Referans 10. Rortveit G, Brown JS, Thom DH, Van Den Eeden SK, Creasman JM, Subak LL. Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort. Obstetrics & Gynecology. 2007;109(6):1396-403. Referans 11. Erk A, Demirtürk F. Berek & Novak Jinekoloji 14 ed. İstanbul: Nobel Tıp Kitabevleri 2011. 1671 p. Referans 12. Mouritsen L, Larsen JP. Symptoms, bother and POPQ in women referred with pelvic organ prolapse. International Urogynecology Journal. 2003;14(2):122-7. Referans 13. Argirovic A, Tulic C, Kadija S, Soldatovic I, Babic U, Nale D. Cross-cultural adaptation and validation of the Serbian version of the Australian pelvic floor questionnaire. Int Urogynecol J. 2015;26(1):131-8. Referans 14. Teleman P, Laurikainen E, Kinne I, Pogosean R, Jakobsson U, Rudnicki M. Relationship between the Pelvic Organ Prolapse Quantification system (POP-Q), the Pelvic Floor Impact Questionnaire (PFIQ-7), and the Pelvic Floor Distress Inventory (PFDI-20) before and after anterior vaginal wall prolapse surgery. Int Urogynecol J. 2015;26(2):195-200. Referans 15. Espuna-Pons M, Fillol M, Pascual MA, Rebollo P, Mora AM, Group FPFDR. Pelvic floor symptoms and severity of pelvic organ prolapse in women seeking care for pelvic floor problems. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2014;177:141-5. Referans 16. Cetinkaya SE, Dokmeci F, Dai O. Correlation of pelvic organ prolapse staging with lower urinary tract symptoms, sexual dysfunction, and quality of life. International urogynecology journal. 2013;24(10):1645-50. Referans 17. Doğan H, Özengin N, Bakar Y, Duran B. Reliability and validity of a Turkish version of the Global Pelvic Floor Bother Questionnaire. International urogynecology journal. 2016:1-5. Referans 18. Bazi T, Kabakian-Khasholian T, Ezzeddine D, Ayoub H. Validation of an Arabic version of the global Pelvic Floor Bother Questionnaire. International Journal of Gynecology & Obstetrics. 2013;121(2):166-9. Referans 19. Peterson TV, Karp DR, Aguilar VC, Davila GW. Validation of a global pelvic floor symptom bother questionnaire. International urogynecology journal. 2010;21(9):1129-35. Referans 20. Lemos N, Korte J, Iskander M, Freeman R, Arunkalaivanan A, Rizk D, et al. Center-by-center results of a multicenter prospective trial to determine the inter-observer correlation of the simplified POP-Q in describing pelvic organ prolapse. International urogynecology journal. 2012;23(5):579-84. Referans 21. Swift S, Morris S, McKinnie V, Freeman R, Petri E, Scotti RJ, et al. Validation of a simplified technique for using the POPQ pelvic organ prolapse classification system. International Urogynecology Journal. 2006;17(6):615-20. Referans 22. Parekh M, Swift S, Lemos N, Iskander M, Freeman B, Arunkalaivanan A, et al. Multicenter inter-examiner agreement trial for the validation of simplified POPQ system. International urogynecology journal. 2011;22(6):645-50. Referans 23. Kaya S, Akbayrak T, Orhan C, Beksaç S. Kadınlarda farklı üriner inkontinans tiplerinde hasta özelliklerinin ve üriner parametrelerin karşılaştırılması: retrospektif bir çalışma. Journal of Exercise Therapy and Rehabilitation. 2015;2(3):93-101. Referans 24. Mouritsen L, Larsen JP. Symptoms, bother and POPQ in women referred with pelvic organ prolapse. Int Urogynecol J 2003;14(2):122-7. Referans 25. Manonai J, Wattanayingcharoenchai R. Relationship between pelvic floor symptoms and POP-Q measurements. Neurourology and urodynamics. 2016;35(6):724. Referans 26. Ghetti C, Gregory WT, Edwards SR, Otto LN, Clark AL. Pelvic organ descent and symptoms of pelvic floor disorders. American journal of obstetrics and gynecology. 2005;193(1):53-7. Referans 27. Salvatore S, Serati M, Siesto G, Cattoni E, Zanirato M, Torella M. Correlation between anatomical findings and symptoms in women with pelvic organ prolapse using an artificial neural network analysis. International urogynecology journal. 2011;22(4):453-9. Referans 28. Barber MD, Neubauer NL, Klein-Olarte V. Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies? American journal of obstetrics and gynecology. 2006;195(4):942-8.